Why COVID patients who could most benefit from Paxlovid still aren't getting it
Briefly

from www.bostonherald.com10 months ago
That kind of sticker shock has stunned thousands of sick Americans since late December, as Pfizer shifted to commercial sales of Paxlovid.
www.bostonherald.comhttps://www.bostonherald.com/2024/03/15/why-covid-patients-who-could-most-benefit-from-paxlovid-still-arent-getting-it/
It's not an easy drug to use. Doctors are wary about prescribing it because of dangerous interactions with common drugs...
www.bostonherald.comhttps://www.bostonherald.com/2024/03/15/why-covid-patients-who-could-most-benefit-from-paxlovid-still-arent-getting-it/
Read at www.bostonherald.com
#covid-19-treatment #paxlovid #access-to-medication #healthcare-costs
[
|
]